| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 22.491 | 31.664 | 40.791 | 56.508 | 63.834 | 72.520 | 114.434 | 136.820 | 149.364 |
| Total Income - EUR | - | 22.491 | 31.664 | 40.791 | 56.508 | 63.836 | 74.037 | 124.168 | 136.822 | 149.408 |
| Total Expenses - EUR | - | 10.870 | 13.202 | 17.987 | 19.762 | 30.406 | 36.981 | 59.988 | 75.663 | 69.070 |
| Gross Profit/Loss - EUR | - | 11.620 | 18.462 | 22.804 | 36.747 | 33.429 | 37.056 | 64.180 | 61.159 | 80.338 |
| Net Profit/Loss - EUR | - | 11.171 | 16.835 | 22.396 | 36.182 | 32.791 | 36.316 | 62.939 | 59.790 | 75.857 |
| Employees | - | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Veroconsult Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 10.243 | 15.543 | 15.257 | 14.962 | 12.301 | 18.145 | 8.822 | 3.272 | 2.737 |
| Current Assets | - | 20.206 | 17.960 | 21.250 | 23.098 | 27.685 | 27.849 | 68.059 | 70.275 | 79.946 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 10.693 | 14.862 | 16.818 | 18.046 | 17.312 | 11.321 | 62.792 | 65.364 | 72.179 |
| Cash | - | 9.513 | 3.098 | 4.432 | 5.052 | 10.373 | 16.528 | 5.267 | 4.911 | 7.767 |
| Shareholders Funds | - | 11.215 | 16.879 | 22.439 | 27.204 | 32.832 | 32.313 | 62.988 | 59.839 | 75.906 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 19.234 | 16.624 | 14.069 | 10.856 | 7.154 | 13.681 | 13.894 | 13.708 | 6.777 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Veroconsult Med Srl